Trends in Healthcare-Acquired Infections Due to Multidrug-Resistant Organisms at a German University Medical Center Before and During the COVID-19 Pandemic

Overview

Journal Microorganisms

Specialty Microbiology

Date 2025 Feb 26

PMID 40005641

Authors

Susanne Kolbe-Busch

Paule Dana Djouela Djoulako

Catalina-Suzana Stingu

Affiliations

Soon will be listed here.

Abstract

Background: Healthcare-acquired infections due to multidrug-resistant organisms (MDR-HAIs) pose globally significant challenges to healthcare systems, leading to increased morbidity, mortality, and healthcare costs. According to the World Health Organization, the COVID-19 pandemic significantly impacted the burden of MDR-HAIs. The aim of this study was to investigate the dynamics and epidemiology of MDR-HAIs in inpatients at the University of Leipzig Medical Center (ULMC) before and during the COVID-19 pandemic.

Methods: We compared data from inpatients with bacterial infections from 2017 to 2019 (pre-COVID-19) and from 2021to 2023 (during COVID-19) in a cross-sectional, monocentric, retrospective survey. This study focused on selected multidrug-resistant organisms (MDROs) and four clinical specimens. We analyzed the risk factors for MDR-HAIs using logistic regression models.

Results: Out of 342,705 inpatients, 32,206 were diagnosed with a bacterial infection. The prevalence increased significantly from 8.09% (pre-COVID-19) to 10.79% (during COVID-19) ( < 0.001), but the proportion of MDROs decreased from 10.14% to 8.07%. The proportions of MDR-HAIs were 59.86% and 56.67%, respectively. The proportion of carbapenem-resistant and increased significantly. The risk of MDR-HAIs during COVID-19 decreased by 18% compared to pre-COVID-19 ( = 0.047). Longer hospital stays increased the risk of MDR-HAIs in both periods. This risk significantly decreased for children and the elderly during COVID-19.

Conclusion: These findings show that it is also important to analyze epidemiological data at the facility level in order to evaluate the effectiveness of infection control practices even during unprecedented health crises like the COVID-19 pandemic.

References

Farfour E, Lecuru M, Dortet L, Le Guen M, Cerf C, Karnycheff F . Carbapenemase-producing Enterobacterales outbreak: Another dark side of COVID-19. Am J Infect Control. 2020; 48(12):1533-1536. PMC: 7529666. DOI: 10.1016/j.ajic.2020.09.015. View

Serra-Burriel M, Keys M, Campillo-Artero C, Agodi A, Barchitta M, Gikas A . Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: Systematic review and meta-analysis. PLoS One. 2020; 15(1):e0227139. PMC: 6953842. DOI: 10.1371/journal.pone.0227139. View

Langford B, Soucy J, Leung V, So M, Kwan A, Portnoff J . Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis. Clin Microbiol Infect. 2022; 29(3):302-309. PMC: 9733301. DOI: 10.1016/j.cmi.2022.12.006. View

Mitchell B, Stewardson A, Kerr L, Ferguson J, Curtis S, Busija L . The incidence of nosocomial bloodstream infection and urinary tract infection in Australian hospitals before and during the COVID-19 pandemic: an interrupted time series study. Antimicrob Resist Infect Control. 2023; 12(1):61. PMC: 10318831. DOI: 10.1186/s13756-023-01268-2. View

Blanco N, OHara L, Harris A . Transmission pathways of multidrug-resistant organisms in the hospital setting: a scoping review. Infect Control Hosp Epidemiol. 2019; 40(4):447-456. PMC: 6897300. DOI: 10.1017/ice.2018.359. View

Hermsen E, Amos J, Townsend A, Becker T, Hargreaves S . Antimicrobial resistance among refugees and asylum seekers: a global systematic review and meta-analysis. Lancet Infect Dis. 2024; 25(1):e34-e43. DOI: 10.1016/S1473-3099(24)00578-4. View

Ilmavirta H, Ollgren J, Raisanen K, Kinnunen T, Hakanen A, Rantakokko-Jalava K . Impact of the COVID-19 pandemic on extended-spectrum β-lactamase producing Escherichia coli in urinary tract and blood stream infections: results from a nationwide surveillance network, Finland, 2018 to 2022. Antimicrob Resist Infect Control. 2024; 13(1):72. PMC: 11227720. DOI: 10.1186/s13756-024-01427-z. View

Lai C, Chen S, Ko W, Hsueh P . Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021; 57(4):106324. PMC: 7972869. DOI: 10.1016/j.ijantimicag.2021.106324. View

Al-Tawfiq J, Tambyah P . Healthcare associated infections (HAI) perspectives. J Infect Public Health. 2014; 7(4):339-44. DOI: 10.1016/j.jiph.2014.04.003. View

10.

Baccolini V, Migliara G, Isonne C, Dorelli B, Barone L, Giannini D . The impact of the COVID-19 pandemic on healthcare-associated infections in intensive care unit patients: a retrospective cohort study. Antimicrob Resist Infect Control. 2021; 10(1):87. PMC: 8177262. DOI: 10.1186/s13756-021-00959-y. View

11.

DAgata E, Varu A, Geffert S, Araos R, Mitchell S, Situ A . Acquisition of Multidrug-resistant Organisms in the Absence of Antimicrobials. Clin Infect Dis. 2018; 67(9):1437-1440. PMC: 6186851. DOI: 10.1093/cid/ciy358. View

12.

Sharifipour E, Shams S, Esmkhani M, Khodadadi J, Fotouhi-Ardakani R, Koohpaei A . Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infect Dis. 2020; 20(1):646. PMC: 7461753. DOI: 10.1186/s12879-020-05374-z. View

13.

Petrosillo N, Petersen E, Antoniak S . Ukraine war and antimicrobial resistance. Lancet Infect Dis. 2023; 23(6):653-654. DOI: 10.1016/S1473-3099(23)00264-5. View

14.

Li J, Wang J, Yang Y, Cai P, Cao J, Cai X . Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis. Antimicrob Resist Infect Control. 2020; 9(1):153. PMC: 7506844. DOI: 10.1186/s13756-020-00819-1. View

15.

Raoofi S, Pashazadeh Kan F, Rafiei S, Hosseinipalangi Z, Noorani Mejareh Z, Khani S . Global prevalence of nosocomial infection: A systematic review and meta-analysis. PLoS One. 2023; 18(1):e0274248. PMC: 9882897. DOI: 10.1371/journal.pone.0274248. View

16.

Kapsner L, Kampf M, Seuchter S, Gruendner J, Gulden C, Mate S . Reduced Rate of Inpatient Hospital Admissions in 18 German University Hospitals During the COVID-19 Lockdown. Front Public Health. 2021; 8:594117. PMC: 7838458. DOI: 10.3389/fpubh.2020.594117. View

17.

Dobrovic K, Skrobo T, Selec K, Jelic M, Civljak R, Persec J . Healthcare-Associated Bloodstream Infections Due to Multidrug-Resistant in COVID-19 Intensive Care Unit: A Single-Center Retrospective Study. Microorganisms. 2023; 11(3). PMC: 10056625. DOI: 10.3390/microorganisms11030774. View

18.

Lin S, Koh J, Aung T, Lim F, Li J, Zou H . Symmetrically Substituted Xanthone Amphiphiles Combat Gram-Positive Bacterial Resistance with Enhanced Membrane Selectivity. J Med Chem. 2017; 60(4):1362-1378. DOI: 10.1021/acs.jmedchem.6b01403. View

19.

Wee L, Venkatachalam I, Sim X, Tan K, Wen R, Tham C . Containment of COVID-19 and reduction in healthcare-associated respiratory viral infections through a multi-tiered infection control strategy. Infect Dis Health. 2021; 26(2):123-131. PMC: 7667403. DOI: 10.1016/j.idh.2020.11.004. View

20.

Morris S, Cerceo E . Trends, Epidemiology, and Management of Multi-Drug Resistant Gram-Negative Bacterial Infections in the Hospitalized Setting. Antibiotics (Basel). 2020; 9(4). PMC: 7235729. DOI: 10.3390/antibiotics9040196. View